<?xml version="1.0" encoding="UTF-8" standalone="no"?><Seed><Category/><Tag1>Compound<Name>Lupeol</Name></Tag1><Tag2>BioAct<Name>anti-fungal activity against fusarium oxysporum and penicillium notatum</Name><Name>anti-inflammatory</Name><Name>antiurolithiatic</Name><Name>diuretic</Name><Name>growth inhibition and apoptosis in SMMC7721</Name><Name>hypotensive</Name><Name>inhibited the proliferation of MDA-MB-231</Name></Tag2><Relation><Pattern>absorption , and</Pattern><Pattern>acid synthesis in</Pattern><Pattern>activity against hep2</Pattern><Pattern>ascites carcinoma in</Pattern><Pattern>bile acid synthesis</Pattern><Pattern>carcinoma in mice</Pattern><Pattern>cells ; markedly</Pattern><Pattern>cholesterol absorption ,</Pattern><Pattern>cholesterol and classic</Pattern><Pattern>cholesterol levels ,</Pattern><Pattern>efficacy against ehrlich</Pattern><Pattern>ehrlich ascites carcinoma</Pattern><Pattern>exhibited antimutagenic ,</Pattern><Pattern>hep2 and mccoy</Pattern><Pattern>inhibited cholesterol absorption</Pattern><Pattern>inhibited tumour promotion</Pattern><Pattern>levels , inhibited</Pattern><Pattern>mccoy cells ;</Pattern><Pattern>mice ; lowered</Pattern><Pattern>plasma cholesterol levels</Pattern><Pattern>promotion ; exhibited</Pattern><Pattern>rats ; showed</Pattern><Pattern>showed cytostatic activity</Pattern><Pattern>showed therapeutic efficacy</Pattern><Pattern>suppressed hepatic cholesterol</Pattern><Pattern>synthesis in rats</Pattern><Pattern>tumour promotion ;</Pattern></Relation></Seed>